OLOZAR-KT is a superior combination ophthalmic solution containing Olopatadine, a mast cell stabilizer and H1-receptor antagonist, and Ketorolac Tromethamine, a nonsteroidal anti-inflammatory drug (NSAID). Enhanced with Trehalose for advanced cell protection.
Olopatadine inhibits the release of histamine and other inflammatory mediators from mast cells, while Ketorolac provides potent anti-inflammatory action by inhibiting prostaglandin synthesis.
Indicated for the temporary relief of ocular itching and inflammation associated with seasonal allergic conjunctivitis.